Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREBOTPilot
DRKS00020401Phase 2Not yet recruiting
- Sponsor
- Heidelberg University Hospital
- Start
- Jan 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of neuronox (2 arms), sponsored by Heidelberg University Hospital. Planned start Jan 2020; status: not yet recruiting.
02
Drugs
neuronox
Beyond the preview
Go deeper on DRKS00020401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00020401.